Cma Genesis Remedies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-12-2024
- Paid Up Capital ₹ 0.10 M
as on 24-12-2024
- Company Age 11 Year, 6 Months
- Last Filing with ROC 31 Mar 2016
- Open Charges ₹ 4.50 M
as on 24-12-2024
- Revenue -0.75%
(FY 2016)
- Profit -84.73%
(FY 2016)
- Ebitda -60.25%
(FY 2016)
- Net Worth -9.17%
(FY 2016)
- Total Assets -9.17%
(FY 2016)
About Cma Genesis Remedies
The Corporate was formerly known as Cma Genesys And Remedies Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.50 M.
Guruprasad Rao, Renu Kulkarni, and Seema Rao serve as directors at the Company.
- CIN/LLPIN
U24233MH2013PTC244393
- Company No.
244393
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jun 2013
- Date of AGM
30 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Cma Genesis Remedies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Guruprasad Rao  | Director | 13-Jun-2013 | Current |
| Renu Kulkarni | Director | 01-Oct-2013 | Current |
| Seema Rao | Director | 13-Jun-2013 | Current |
Financial Performance of Cma Genesis Remedies.
Cma Genesis Remedies Private Limited, for the financial year ended 2016, experienced Minor drop in revenue, with a 0.75% decrease. The company also saw a substantial fall in profitability, with a 84.73% decrease in profit. The company's net worth dipped by a decrease of 9.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cma Genesis Remedies?
In 2016, Cma Genesis Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Genesis Remedies Private LimitedActive 18 years 8 months
Guruprasad Rao and Seema Rao are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 21 Nov 2013 | ₹4.50 M | Open |
How Many Employees Work at Cma Genesis Remedies?
Unlock and access historical data on people associated with Cma Genesis Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cma Genesis Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cma Genesis Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
